NJ S4294

Requires New Jersey Medicaid to cover medically necessary ovulation enhancing drugs and related medical services for beneficiaries ages 21-44 experiencing infertility, contingent on federal financial participation

Covered medical services include office visits, hysterosalpingograms, pelvic ultrasounds, and blood testing related to prescribing and monitoring ovulation enhancing drug use

Limits coverage to three cycles of treatment per lifetime per beneficiary

Defines infertility as failure to establish pregnancy after 12 months of unprotected intercourse for ages 21-34, or after 6 months for ages 35-44, with protections ensuring the definition cannot deny or delay treatment based on relationship status or sexual orientation

Directs the Commissioner of Human Services to apply for necessary federal waivers or state plan amendments and adopt implementing regulations, with the act taking effect on the first day of the fourth month following enactment